Mark Niosi

3PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 14, 2024
Clotrimazole Identified as a Selective UGT2B4 Inhibitor Using Canagliflozin-2'-O-Glucuronide Formation as a Selective UGT2B4 Probe Reaction.

Kimberly Lapham, Nicholas Ferguson, Mark Niosi

|May 08, 2024
The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite.

Martin E Dowty, Ruolun Qiu, Alyssa Dantonio

Pageof 1